secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001178670-25-000062
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam shareholders approve officer exculpation charter amendment, re-elect four directors
--------------------------------------------------------------------------------

- Filed certificate of amendment to allow officer exculpation; approved with 111.5M for, 7.1M against.
- Re-elected four Class III directors (Carolyn Bertozzi, Margaret Hamburg, Colleen Reitan, Amy Schulman) with majority support.
- Approved Second Amended and Restated 2018 Stock Incentive Plan (114.0M for, 4.6M against).
- Non-binding advisory vote on executive compensation passed (111.7M for, 6.9M against).
- Ratified PwC as independent auditors for FY2025 (117.0M for, 6.4M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000117867025000062/0001178670-25-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000117867025000062/alny-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001178670-25-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer